Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours.

by Tai, L.K., Zhang, D.H., Wong, L.L., Koay, E.S.
Published 2016

Proteomics of breast cancer: Enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors

by Zhang, D.-H., Tai, L.K., Sethi, S.K., Koay, E.S.C., Wong, L.L.
Published 2011

Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer

by Zhang, D.-H., Wong, L.L., Tai, L.K., Koay, E.S.C., Hewitt, R.E.
Published 2012

Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study

by Zhang, D., Koay, E.S.-C., Tai, Y.-C., Wong, C.-H.S., Chen, C.-S., Tai, L.-K.
Published 2012

Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study

by Zhang, D., Koay, E.S.-C., Tai, Y.-C., Wong, C.-H.S., Chen, C.-S., Tai, L.-K.
Published 2011

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

by Zhang, D., Chiu, L.-L., Sethi, S.K., Koay, E.S.C., Tai, L.K., Wong, L.L.
Published 2012

Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu status

by Zhang, D., Sethi, S.K., Koay, E.S.C., Tai, L.K., Wong, L.L., Putti, T.C., Teh, M.
Published 2012